Radiotherapy-Associated Atrial Fibrillation
- Conditions
- Atrial Fibrillation New Onset
- Interventions
- Diagnostic Test: ECG
- Registration Number
- NCT05927246
- Lead Sponsor
- Istanbul University
- Brief Summary
Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer.
Each patient will have 12 lead ECG prior, and daily during radiotherapy.
- Detailed Description
Collected data will be truly anonymised and individuals will no longer identifiable, and than evaluated for occurrence of atrial fibrillation.
Inclusing Criteria:
1. Patients with radiotherapy for thoracic malignancy or breast cancer
2. Between 18-99 years-old
Exclusion Criteria:
1. Patients with history of radiotherapy
2. Patients with history of atrial fibrillation
3. Patients with pacemaker implantation
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 400
- Patients with radiotherapy for thoracic malignancy or breast cancer
- Between 18-99 years-old
- Patients with history of radiotherapy
- Patients with history of atrial fibrillation
- Patients with pacemaker implantation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with Breast Cancer ECG All patients undergoing RT for Breast Cancer Patients with Thoracic Malignancies ECG All patients undergoing RT for Thoracic Malignancies
- Primary Outcome Measures
Name Time Method Onset time of atrial fibrillation 1 day During radiotherapy Onset time of atrial fibrillation
Occurrence of atrial fibrillation 1 day During radiotherapy Occurrence of atrial fibrillation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Istanbul Faculty of Medicine
🇹🇷Fatih, Istanbul, Turkey
Istanbul Faculty of Medicine🇹🇷Fatih, Istanbul, Turkey